Physician

Michael C Reed, MD

According to 2025 Medicare claims, Michael Reed, MD (NPI: 1346396967) practices interventional cardiology in the Missoula, MT market, with the plurality of this provider's patient population coming from Missoula, MT. This provider's primary affiliated billing organization is PROVIDENCE HEALTH & SERVICES MT (NPI: 1427096585; TIN: 810231793) and primary practice location at 59802-4096. Reed is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), MountainStar Care Partners ACO (ACO ID: A5181), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Reed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 988 traditional Medicare patients, billed 2,043 HCPCS/CPT codes, and received $225,554 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 705 prescription claims across 208 beneficiaries totaling $75,214 in drug costs, led by Brilinta (Ticagrelor). 2016 DME data shows 12 claims. Open Payments data shows 31 records totaling $221,225. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	816	1,594	$259,493
2016	845	1,756	$309,804
2017	1,236	2,233	$288,844
2018	1,153	2,390	$307,761
2019	1,230	2,513	$340,782
2020	1,174	2,231	$232,573
2021	978	2,133	$254,465
2022	1,050	2,177	$242,280
2023	1,060	2,252	$240,461
2024	988	2,043	$225,554

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	430	2,491	$93,849
2016	375	1,947	$85,800
2017	444	1,958	$101,450
2018	426	1,974	$110,181
2019	402	1,779	$115,973
2020	409	1,578	$113,540
2021	338	1,344	$113,336
2022	272	962	$85,782
2023	253	862	$107,670
2024	208	705	$75,214

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$24,009
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	146	147	$179
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	96	96	$120
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	130	130	$11
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	278	307	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	490	585	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brilinta	Ticagrelor	27	1,799	$25,204
Eliquis	Apixaban	12	766	$14,886
Xarelto	Rivaroxaban	11	810	$13,867
Clopidogrel	Clopidogrel Bisulfate	189	15,220	$2,019
Prasugrel Hcl	Prasugrel Hcl	27	2,240	$1,822

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$700	Integra LifeSciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	15	$220,525	Edwards Lifesciences Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael C. Reed, MD?

Tedicare shows public-source Medicare data for Michael C. Reed, MD (NPI 1346396967), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael C. Reed, MD have ACO affiliation data?

Michael C. Reed, MD is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), MountainStar Care Partners ACO (MSSP, ACO ID A5181), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Michael C. Reed, MD?

Michael C. Reed, MD is linked to PROVIDENCE HEALTH & SERVICES MT (billing NPI 1427096585) in the available physician profile data.

Does Michael C. Reed, MD have Open Payments data?

Michael C. Reed, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.